🇺🇸 Immunosuppressive Agents in United States
118 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 118
Most-reported reactions
- Pyrexia — 17 reports (14.41%)
- Pregnancy — 15 reports (12.71%)
- Drug Exposure During Pregnancy — 13 reports (11.02%)
- Abortion Spontaneous — 12 reports (10.17%)
- Blood Pressure Decreased — 12 reports (10.17%)
- Nephrogenic Systemic Fibrosis — 11 reports (9.32%)
- Pain — 11 reports (9.32%)
- Arthralgia — 9 reports (7.63%)
- Diarrhoea — 9 reports (7.63%)
- Dyspnoea — 9 reports (7.63%)
Other Immunology approved in United States
Frequently asked questions
Is Immunosuppressive Agents approved in United States?
Immunosuppressive Agents does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Immunosuppressive Agents in United States?
Loma Linda University is the originator. The local marketing authorisation holder may differ — check the official source linked above.